Dr. Kebir H. Bedran, MD

Dr. Bedran practices at West Kendall Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Bedran's NPI, 1093134033, was assigned on April 7, 2014. Dr. Bedran graduated from Universidad de Cartegena in 2002. Dr. Bedran holds Florida license ME118927.

Dr. Bedran's primary practice is West Kendall Baptist Hospital, at 9555 Sw 162 Ave, Miami, FL 33196 in Miami-Dade County. The practice phone is (786) 467-2000.

Dr. Bedran's primary practice is West Kendall Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Bedran is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Baptist Health Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bedran practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Bedran's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Bedran is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bedran's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists acute respiratory failure, anemia, cellulitis, cirrhosis, congestive heart failure, electrolyte disorders, gastrointestinal inflammation and gastrointestinal obstruction among the conditions Dr. Bedran treats.

CMS data shows 515 Medicare services from Dr. Bedran across 4 procedure codes in 2024, for 230 Medicare patients. Medicare paid $53,861 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 230 Medicare patients who saw Dr. Bedran in 2024. The largest group is 85 and over, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 70% are also on Medicaid. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bedran's median patient age at 68, with 53% women.

In 2024, Dr. Bedran wrote 364 Medicare Part D claims for 179 patients. 89% of them were for generic drugs. CMS names the drug for 93 of them, across 7 drugs with 11 or more claims each, at $11,041 in total drug cost. In 2023, CMS named 134 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Bedran for performance year 2024, reported through an alternative payment model (APM). Dr. Bedran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Bedran, published from 2015 to 2024. 2023 was the busiest year, with 3. Dr. Bedran has published most often in Cureus. Dr. Bedran's most frequent co-authors are Waqas Jehangir, MBBS, MD, Abdalla Mohamed Yousif, MD and Emily Quintero, MD.

CMS Open Payments shows 24 general payments to Dr. Bedran from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $358.

Dmand AI lists 4 awards for Dr. Bedran, most recently Excellence in Clinical Teaching in Internal Medicine Award in 2025.

Dr. Bedran graduated from Universidad de Cartegena in 2002. Dr. Bedran is a member of ACP.

Dr. Bedran is in network with 6 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.